|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash and due from banks | |||||||||||||||||||
| Money market funds and interest-bearing deposits in other banks | |||||||||||||||||||
| Federal funds sold | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Held to maturity, at amortized cost-fair value of $112 in 2022 | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Held to maturity, at amortized cost - fair value of $113 and $112 in 2023 and 2022, respectively | |||||||||||||||||||
| Available for sale, at fair value | |||||||||||||||||||
| Securities: | |||||||||||||||||||
| Available for sale, at fair value | |||||||||||||||||||
| Other investments, at cost | |||||||||||||||||||
| Loans held for sale, at fair value | |||||||||||||||||||
| Loans held for investment, net of deferred fees and costs | |||||||||||||||||||
| Net loans held for investment | |||||||||||||||||||
| Less: allowance for credit losses | |||||||||||||||||||
| Net loans held for investment | |||||||||||||||||||
| Bank premises and equipment, net | |||||||||||||||||||
| OREO | |||||||||||||||||||
| Other real estate owned | |||||||||||||||||||
| Interest receivable | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Bank owned life insurance | |||||||||||||||||||
| Deferred tax asset, net | |||||||||||||||||||
| Assets held for sale | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Deposits: | |||||||||||||||||||
| Noninterest bearing | |||||||||||||||||||
| Interest bearing | |||||||||||||||||||
| Total deposits | |||||||||||||||||||
| Short-term debt | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Shareholders' Equity | |||||||||||||||||||
| Common stock, $5 par value, 6,000,000 shares authorized, 3,551,661 (2026) and 3,525,884 (2025) shares issued and outstanding | |||||||||||||||||||
| Common stock held by deferred compensation trust, at par, 34,970 (2026) and 31,176 (2025) shares | |||||||||||||||||||
| Additional paid in capital | |||||||||||||||||||
| Additional paid in capital attributed to deferred compensation trust | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total Shareholders' Equity | |||||||||||||||||||
| Total Liabilities and Shareholders' Equity | |||||||||||||||||||
Loading...
